• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid.

作者信息

Kähler C M, Kieselbach G F, Reinisch N, Troger J, Göttinger W, Wiedermann C J

机构信息

Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Austria.

出版信息

Eur J Pharmacol. 1994 Sep 12;262(3):261-9. doi: 10.1016/0014-2999(94)90740-4.

DOI:10.1016/0014-2999(94)90740-4
PMID:7813591
Abstract

Proliferative vitreoretinopathy is a severe reactive process which leads to the formation of cellular membranes on the surface of the retina and in the vitreous. We determined the fibroblast growth-promoting activity of intraocular fluid from patients suffering from proliferative vitreoretinopathy, retinal detachment or cataract and further evaluated the effect of acetylsalicylic acid on growth-stimulated fibroblasts. The results demonstrated a significant enhancement of growth-promoting activity of intraocular fluid in proliferative vitreoretinopathy as compared to that of control samples. We showed that the augmented growth-promoting activity of intraocular fluid in proliferative vitreoretinopathy was significantly antagonized by inhibition of cyclooxygenase with acetylsalicylic acid (ID50 approximately 5 microM). In contrast, no significant effect was seen in corresponding control experiments. The findings suggest that metabolites of the cyclooxygenase pathway are involved in the regulation of enhanced intraocular fluid-induced fibroblast proliferation in proliferative vitreoretinopathy and that acetylsalicylic acid might be useful as an antiproliferative agent in intraocular fibrogenesis.

摘要

相似文献

1
Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid.
Eur J Pharmacol. 1994 Sep 12;262(3):261-9. doi: 10.1016/0014-2999(94)90740-4.
2
Induction of arachidonic acid metabolite release by human fibroblasts in proliferative vitreoretinopathy.增殖性玻璃体视网膜病变中人类成纤维细胞诱导花生四烯酸代谢物释放
Eur J Pharmacol. 1998 Jan 2;341(1):111-7. doi: 10.1016/s0014-2999(97)01466-0.
3
A sustained dual drug delivery system for proliferative vitreoretinopathy.一种用于增殖性玻璃体视网膜病变的持续双药递送系统。
Drug Deliv. 2020 Dec;27(1):1461-1473. doi: 10.1080/10717544.2020.1833382.
4
Pathologic human vitreous promotes contraction by fibroblasts. Implications for proliferative vitreoretinopathy.病理性人类玻璃体可促进成纤维细胞收缩。对增殖性玻璃体视网膜病变的影响。
Arch Ophthalmol. 1995 Dec;113(12):1545-53. doi: 10.1001/archopht.1995.01100120075013.
5
Alkylphosphocholines: a new approach to inhibit cell proliferation in proliferative vitreoretinopathy.
Dev Ophthalmol. 2009;44:46-55. doi: 10.1159/000223945. Epub 2009 Jun 3.
6
SU9518 inhibits proliferative vitreoretinopathy in fibroblast and genetically modified Müller cell-induced rabbit models.SU9518 抑制成纤维细胞和基因修饰 Müller 细胞诱导的兔增生性玻璃体视网膜病变。
Invest Ophthalmol Vis Sci. 2013 Feb 19;54(2):1392-7. doi: 10.1167/iovs.12-10320.
7
Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous.他汀类药物预防增生性玻璃体视网膜病变:培养细胞中的细胞反应和玻璃体内的临床他汀类药物浓度。
Sci Rep. 2021 Jan 13;11(1):980. doi: 10.1038/s41598-020-80127-1.
8
Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.病理性玻璃体可使细胞系来源(而非供体来源)的视网膜色素上皮细胞在培养中呈现增殖性玻璃体视网膜病变样特征。
Clin Exp Ophthalmol. 2014 Nov;42(8):745-60. doi: 10.1111/ceo.12307. Epub 2014 Jun 23.
9
The role of thrombin in proliferative vitreoretinopathy.凝血酶在增生性玻璃体视网膜病变中的作用。
Invest Ophthalmol Vis Sci. 2014 Jul 11;55(7):4659-66. doi: 10.1167/iovs.14-14818.
10
Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.用于治疗增殖性玻璃体视网膜病变的增殖细胞核抗原核酶
Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3338-48.

引用本文的文献

1
Effect of Oral Prednisone on the Prevention and Management of Proliferative Vitreoretinopathy After Open-Globe Injury.口服泼尼松对开放性眼球损伤后增殖性玻璃体视网膜病变的预防及治疗作用
J Vitreoretin Dis. 2024 Feb 13;8(2):168-172. doi: 10.1177/24741264241229262. eCollection 2024 Mar-Apr.
2
Choline Salicylate Analysis: Chemical Stability and Degradation Product Identification.水杨酸胆碱分析:化学稳定性和降解产物鉴定。
Molecules. 2019 Dec 22;25(1):51. doi: 10.3390/molecules25010051.
3
Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study.
新型硅油/乙酰水杨酸混悬液用于增殖性玻璃体视网膜病变眼内填塞的安全性和可行性:奥地利临床多中心研究的初步结果。
Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1193-8. doi: 10.1007/s00417-010-1389-7. Epub 2010 Apr 28.
4
A rabbit model of proliferative vitreoretinopathy induced by injection of astrocytic cultures.通过注射星形胶质细胞培养物诱导的增殖性玻璃体视网膜病变兔模型。
Cell Mol Neurobiol. 1999 Dec;19(6):759-73. doi: 10.1023/a:1006957123672.
5
Platelets, aspirin, and cardiovascular disease.血小板、阿司匹林与心血管疾病。
Postgrad Med J. 1998 Oct;74(876):587-91. doi: 10.1136/pgmj.74.876.587.